NCT02835924View on ClinicalTrials.gov

Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC

PHASE2CompletedINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2019

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Regorafenib

Trial Locations (1)

28007

Spanish Cooperative Group for the Treatment of Digestive Tumors, Madrid

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

OTHER

NCT02835924 - Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC | Biotech Hunter | Biotech Hunter